Cargando…
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038556/ https://www.ncbi.nlm.nih.gov/pubmed/33916399 http://dx.doi.org/10.3390/ijerph18073786 |
_version_ | 1783677402783678464 |
---|---|
author | Yoshihara, Tatsuya Ito, Kazuya Zaitsu, Masayoshi Chung, Eunhee Aoyagi, Izumi Kaji, Yoshikazu Tsuru, Tomomi Yonemura, Takuma Yamaguchi, Koji Nakayama, Shinichi Tanaka, Yosuke Yurino, Nobuo Koyanagi, Hideki Matsuki, Shunji Urae, Ryuji Irie, Shin |
author_facet | Yoshihara, Tatsuya Ito, Kazuya Zaitsu, Masayoshi Chung, Eunhee Aoyagi, Izumi Kaji, Yoshikazu Tsuru, Tomomi Yonemura, Takuma Yamaguchi, Koji Nakayama, Shinichi Tanaka, Yosuke Yurino, Nobuo Koyanagi, Hideki Matsuki, Shunji Urae, Ryuji Irie, Shin |
author_sort | Yoshihara, Tatsuya |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03–0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-8038556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80385562021-04-12 SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan Yoshihara, Tatsuya Ito, Kazuya Zaitsu, Masayoshi Chung, Eunhee Aoyagi, Izumi Kaji, Yoshikazu Tsuru, Tomomi Yonemura, Takuma Yamaguchi, Koji Nakayama, Shinichi Tanaka, Yosuke Yurino, Nobuo Koyanagi, Hideki Matsuki, Shunji Urae, Ryuji Irie, Shin Int J Environ Res Public Health Communication Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03–0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2. MDPI 2021-04-05 /pmc/articles/PMC8038556/ /pubmed/33916399 http://dx.doi.org/10.3390/ijerph18073786 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Yoshihara, Tatsuya Ito, Kazuya Zaitsu, Masayoshi Chung, Eunhee Aoyagi, Izumi Kaji, Yoshikazu Tsuru, Tomomi Yonemura, Takuma Yamaguchi, Koji Nakayama, Shinichi Tanaka, Yosuke Yurino, Nobuo Koyanagi, Hideki Matsuki, Shunji Urae, Ryuji Irie, Shin SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title | SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title_full | SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title_fullStr | SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title_full_unstemmed | SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title_short | SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan |
title_sort | sars-cov-2 seroprevalence among healthcare workers in general hospitals and clinics in japan |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038556/ https://www.ncbi.nlm.nih.gov/pubmed/33916399 http://dx.doi.org/10.3390/ijerph18073786 |
work_keys_str_mv | AT yoshiharatatsuya sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT itokazuya sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT zaitsumasayoshi sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT chungeunhee sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT aoyagiizumi sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT kajiyoshikazu sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT tsurutomomi sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT yonemuratakuma sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT yamaguchikoji sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT nakayamashinichi sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT tanakayosuke sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT yurinonobuo sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT koyanagihideki sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT matsukishunji sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT uraeryuji sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan AT irieshin sarscov2seroprevalenceamonghealthcareworkersingeneralhospitalsandclinicsinjapan |